SCHEMBL17833159

SCHEMBL17833159

O=P(O)(O)CCNCCI

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR2 O95136 9/20 0.43
S1PR1 P21453 9/20 0.43
S1PR3 Q99500 9/20 0.43
S1PR4 O95977 8/20 0.43
S1PR5 Q9H228 1/20 0.43
TYMS P04818 1/20 0.41
ALDH1A1 P00352 1/20 0.38
PGK1 P00558 1/20 0.38
PGK2 P07205 1/20 0.38
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
LMNA P02545 1/20 0.35
CYP3A4 P08684 1/20 0.35
NFKB1 P19838 1/20 0.35
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17833051 0.88 S1PR2 (0.59) S1PR2S1PR1S1PR3S1PR4S1PR5
SCHEMBL4966489 0.86 TYMS (0.53) S1PR2S1PR1S1PR3S1PR4S1PR5
SCHEMBL2045907 0.76 S1PR2 (0.45) S1PR2S1PR1S1PR3S1PR4S1PR5
SCHEMBL5595395 0.74 S1PR2 (0.59) S1PR2S1PR1S1PR3S1PR4S1PR5
SCHEMBL16625434 0.74 S1PR2 (0.43) S1PR2S1PR1S1PR3S1PR4S1PR5
SCHEMBL1479560 0.74 LMNA (0.59) S1PR2S1PR1S1PR3S1PR4S1PR5
SCHEMBL9792362 0.74 TYMS (0.48) S1PR2S1PR1S1PR3S1PR4S1PR5
SCHEMBL2516244 0.74
SCHEMBL1359350 0.72
SCHEMBL8768407 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017214462-A2 ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES ABBVIE INC. (US) 2017-12-14 WO disclosed
WO-2017214282-A1 ANTI-EGFR ANTIBODY DRUG CONJUGATES ABBVIE INC. (US) 2017-12-14 WO disclosed
WO-2017214335-A1 ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES ABBVIE INC. (US) 2017-12-14 WO disclosed
WO-2016094509-A1 BCL XL INHIBITORY COMPOUNDS HAVING LOW CELL PERMEABILITY AND ANTIBODY DRUG CONJUGATES INCLUDING THE SAME ABBVIE INC. (US) 2016-06-16 WO disclosed